• No results found

University of Groningen Off-label use of antipsychotic medication in people with intellectual disabilities Ramerman, Lotte

N/A
N/A
Info
Downloaden
Protected

Academic year: 2021

Share "University of Groningen Off-label use of antipsychotic medication in people with intellectual disabilities Ramerman, Lotte"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Download het nu ( 2 pagina )

Hele tekst

(1)

University of Groningen

Off-label use of antipsychotic medication in people with intellectual disabilities

Ramerman, Lotte

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Ramerman, L. (2019). Off-label use of antipsychotic medication in people with intellectual disabilities:

adherence to guidelines, long-term effectiveness, and effects on quality of life. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

STELLINGEN behorende bij het proefschrift

Off-label use of antipsychotic medication in people with intellectual disabilities

1. Wanneer risperidon langdurig wordt gebruik voor het verminderen van gedragsproblemen, moet afbouw altijd overwogen worden

2. Het gebruik van richtlijn adviezen omtrent antipsychotica kan bevorderd worden door ze te vertalen naar organisatie specifiek behandelbeleid. 3. Het jaarlijks monitoren van bijwerkingen van antipsychotica binnen

organisaties die zorg bieden voor mensen met een verstandelijke beperking en organisaties voor geestelijke gezondheidszorg zou onderdeel moeten zijn van de normale klinische praktijk.

4. Wanneer gedragsproblemen behandeld worden met antipsychotica, is het gepast om deze behandeling te evalueren met een kwaliteit van leven schaal.

5. Gerandomiseerde klinische trials zijn ondanks de moeilijkheden bij het toepassen van dit onderzoeksdesign in deze populatie een belangrijke methode bij het onderzoeken van de effectiviteit van behandelingen bij mensen met een verstandelijke beperking.

6. Het voorschrijven van risperidon bij gedragsproblemen zou vermeden moet worden.

Referenties

Download het nu ( PDF - 2 pagina - 183.27 KB )

GERELATEERDE DOCUMENTEN

University of Groningen Off-label use of antipsychotic medication in people with intellectual disabilities Ramerman, Lotte

Off-label use of antipsychotic medication in people with intellectual disabilities: adherence to guidelines, long-term effectiveness, and effects on quality of life..

University of Groningen Off-label use of antipsychotic medication in people with intellectual disabilities Ramerman, Lotte

The following three chapters describe the effects of antipsychotic drugs on challenging behaviour and quality of life in people with intellectual disabilities, who have

University of Groningen Off-label use of antipsychotic medication in people with intellectual disabilities Ramerman, Lotte

We studied randomly selected pharmaceutical and medical records of clients with intellectual disabilities who had been prescribed antipsychotic drugs from two types of settings: (1)

University of Groningen Off-label use of antipsychotic medication in people with intellectual disabilities Ramerman, Lotte

Examples of these guidelines are from the National Institute for Health and Care Excellence (NICE) and the Dutch association for Intellectual Disability physicians (NVAVG)

University of Groningen Off-label use of antipsychotic medication in people with intellectual disabilities Ramerman, Lotte

Challenging behaviour and physical symptoms that may be related to antipsychotic drugs were more associated with HQoL, as measured by the RAND-36, than with the

University of Groningen Off-label use of antipsychotic medication in people with intellectual disabilities Ramerman, Lotte

Health-related quality of life was measured at baseline and at 16 weeks and 40 weeks after baseline, by means of the RAND-36 (domains on physical well-being, role limitations

University of Groningen Off-label use of antipsychotic medication in people with intellectual disabilities Ramerman, Lotte

In order to create more clarity on the long-term effectiveness of risperidone in reducing challenging behaviours in people with intellectual disabilities, we set up a study comparing

University of Groningen Healthy lifestyle of people with intellectual disabilities Steenbergen, Rianne

Een ondersteunende omgeving, kennis over gedragsverandering en richtlijnen voor gezonde leefstijl vormen de basis van de leefstijlaanpak binnen zorgorganisaties die mensen met